6533b7cffe1ef96bd1258e79
RESEARCH PRODUCT
Macular edema: Miscellaneous.
Jost B. JonasCatherine Creuzot-garcherSebastian Wolfsubject
medicine.medical_specialtyEye Diseasesgenetic structuresVitreomacular tractionPrimary diseaseTreatment useMacular EdemaHemangiomaOphthalmologyProstaglandins SyntheticmedicineHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansMacular edemaRadiotherapymedicine.diagnostic_testbusiness.industryRetinal detachmentGeneral MedicineFunctional recoverymedicine.diseaseFluorescein angiographyeye diseasesOphthalmology[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organssense organsOphthalmic Solutionsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologydescription
International audience; Abstract. This article provides the reader with practical information to be applied to the various remaining causes of macular edema. Some macular edemas linked to ocular diseases like radiotherapy after ocular melanomas remained of poor functional prognosis due to the primary disease. On the contrary, macular edemas occurring after retinal detachment or after some systemic or local treatment use are often temporary. Macular edema associated with epiretinal membranes or vitreomacular traction is the main cause of poor functional recovery. However, the delay to observe a significant improvement of vision after surgery should be long, as usually observed in tractional myopic vitreoschisis. Finally, some circumstances of macular edemas such as hemangiomas or macroaneurysms should be treated, if symptomatic, with the treatments currently used in diabetic macular edema or exudative macular degeneration.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2010-11-11 |